Skip to main content
logo
Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.63
+0.36 (6.74%)
At close: Nov 9, 2026, 4:00 PM EST
5.61
-0.01 (-0.27%)
After-hours: Nov 9, 2026, 7:30 PM EST

RGC Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2,7893,0178,42644300450
Market Cap Growth
-56.68%-64.19%19171.44%-85.42%-33.42%-
Enterprise Value
2,7753,0158,41839284452
Last Close Price
5.636.0917.040.090.610.91

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PB Ratio
208.95226.041733.675.3225.0126.36
P/TBV Ratio
208.95226.041733.675.3224.9226.39

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.020.020.110.010.040.05
Net Debt / Equity Ratio
-1.04-1.04-0.90-0.96-0.93-0.92
Net Debt / EBITDA Ratio
1.191.191.181.781.862.10
Net Debt / FCF Ratio
1.811.811.331.972.232.59
Quick Ratio
10.7510.757.3841.1319.0628.42
Current Ratio
10.7710.777.3941.9219.1528.46
Return on Equity (ROE)
-128.53%-128.53%-54.81%-43.18%-41.71%-116.10%
Return on Assets (ROA)
-71.54%-71.54%-33.20%-28.11%-25.59%-51.87%
Return on Capital Employed (ROCE)
-87.40%-87.40%-74.00%-57.50%-52.20%-43.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-0.42%-0.39%-0.04%-9.84%-1.96%-1.65%
FCF Yield
-0.28%-0.26%-0.04%-9.16%-1.66%-1.34%
Buyback Yield / Dilution
-0.02%-0.02%---1.62%-28.06%
SEC Filings: 10-K · 10-Q